GLP-1 Drug Can Cause Rare, Potentially Blinding Side Effect, EMA Warns

(MedPage Today) — A potentially blinding condition is a very rare side effect of the GLP-1 receptor agonist semaglutide (Ozempic, Wegovy, Rybelsus), the European Medicines Agency (EMA) concluded.
Following a review of all available data, the…

Source link : https://www.medpagetoday.com/ophthalmology/generalophthalmology/115938

Author :

Publish date : 2025-06-06 15:06:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
	1	2	3	4	5	6
7	8	9	10	11	12	13
14	15	16	17	18	19	20
21	22	23	24	25	26	27
28	29	30	31

GLP-1 Drug Can Cause Rare, Potentially Blinding Side Effect, EMA Warns

Experts Suggest NHS Heart Risk Checks from Age 25

Women find other women’s faces even more attractive than men do

Related Posts

Most on Wegovy a Year Later; Food Label Weight Stigma; Make Your Own GLP-1 Drugs?

Proton Pump Inhibitors and Hypertension; AI Fetal Cardiac Scans; ‘Work Diet’

Fixable Factors Help Drive Disparities in Access to COVID Treatment

A Neanderthal-shaped skull may explain why some people get headaches

Synthetic Nicotine Storms Onto the Vaping Scene

How to Have ‘The Talk’ — About Vaccines

Most on Wegovy a Year Later; Food Label Weight Stigma; Make Your Own GLP-1 Drugs?

Proton Pump Inhibitors and Hypertension; AI Fetal Cardiac Scans; ‘Work Diet’

Fixable Factors Help Drive Disparities in Access to COVID Treatment

A Neanderthal-shaped skull may explain why some people get headaches

Synthetic Nicotine Storms Onto the Vaping Scene

How to Have ‘The Talk’ — About Vaccines

Shrinking Antarctic sea ice is warming the ocean faster than expected

‘Notable’ rise in dads over 60 in England and Wales

Categories

Archives